论文信息 - Efficacy and Safety Results From a Phase II, Placebo‐Controlled Study of Onartuzumab Plus First‐Line Platinum‐Doublet Chemotherapy for Advanced Squamous Cell Non–Small‐Cell Lung Cancer - 字舞流文

Efficacy and Safety Results From a Phase II, Placebo‐Controlled Study of Onartuzumab Plus First‐Line Platinum‐Doublet Chemotherapy for Advanced Squamous Cell Non–Small‐Cell Lung Cancer

R. Govindan | F. Hirsch | D. Gandara | F. Braiteh | T. Cosgriff | D. Isla | S. Phan | C. Belda-Iniesta | A. Rittmeyer | M. Boyer | Z. Zvirbule | M. Ueda | Ž. Zvirbule